3DE-30079-11816
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 563 / MN
- Registered
- 2021-09-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-02
Registered in v-safe
-
2021-09-02
Dose 1 — Pfizer-BioNTech
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
-
2021-09-23
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-23
-
2021-09-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-25
- 2021-09-26
- 2021-09-27
-
2021-10-09
Survey response — day 14, dose 2MedDRA: Cough, Eye pruritus, Lacrimation increased, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, Sinus congestion, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Cold: sore throat, cough, chest and sinus congestion, itchy watery eyes, runny nose · Healthcare visit (other): Messaged obgynMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — day 14, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-10-14
- 2021-10-21
- 2021-11-04
- 2021-12-07
- 2021-12-23
- 2022-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-02 | Pfizer-BioNTech | No |
| 2 | 2021-09-23 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-09 | Unsuccessful |
Free text
Release 10 — day 14, dose 2
Symptoms: Cold: sore throat, cough, chest and sinus congestion, itchy watery eyes, runny nose
Healthcare visit (other): Messaged obgyn
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release